Chinese maker of orthopedic implants backed by US media company International Data Group's local venture fund, IDG-Accel, starts $75m flotation process.

China Kanghui, a Chinese maker of orthopedic implants backed by US media company International Data Group’s local venture fund, IDG-Accel, has filed for a $75m flotation in New York.

Morgan Stanley and Piper Jaffray are co-lead underwriters for Kanghui’s initial public offering (IPO).

IDG-Accel owns 21.5% of Kanghui before the IPO, with VCs SIG China Investments (18.4%), TDF Capital (12.4%) and CDH Venture Capital (9%).

Kanghui has 98.8m shares and IDG-Accel was part of its first investment round…